Please select the option that best describes you:
What regimen would you choose for patients with breast cancer requiring adjuvant chemotherapy whose livelihoods depend on fine dexterity (such as a professional musician)?
Would you use a regimen with lower incidence of neurotoxicity such as CMF or a taxane-based regimen with a low threshold to dose-reduce?
Answer from: Medical Oncologist at Academic Institution
The appropriate treatment depends on the clinical presentation of the breast cancer so that the risks/benefits of recurrence vs side effects are properly taken into account. A stage 3 TNBC would generally require a 3rd generation anthracycline/taxane regimen for optimal outcomes. A better approach w...
Sign in or Register to read more